Dietary starch and related polysaccharides

Dietary starch and related polysaccharides are complex carbohydrates consisting of numerous glucose units joined by glycosidic bonds, serving as the primary energy source in the human diet [1]. These molecules, including amylose and amylopectin, undergo enzymatic hydrolysis by salivary and pancreatic alpha-amylase, followed by further breakdown by intestinal brush-border alpha-glucosidases into absorbable glucose [2]. While starch itself is a nutrient substrate rather than a biological protein target like a receptor or enzyme, its metabolic processing is a key therapeutic focus for managing glycemic control [3].\n\nPharmacological intervention typically involves alpha-glucosidase inhibitors, such as acarbose and miglitol, which competitively inhibit the enzymes responsible for starch digestion [4]. This inhibition delays the absorption of glucose, effectively reducing postprandial hyperglycemia in patients with Type 2 diabetes [4]. Beyond its role as a fuel source, the rate of starch digestion and the presence of resistant starch significantly impact metabolic health and gut microbiota composition [5]. Excessive consumption of rapidly digestible starches is a major contributor to the global prevalence of obesity and metabolic syndrome [1]. Consequently, starch is a central component in dietary and pharmacological strategies aimed at controlling metabolic diseases [3].

Other names

AmylumComplex carbohydratesGlucansAmyloseAmylopectinGlycans

Competitive inhibition of alpha-amylase and alpha-glucosidase enzymes to delay the hydrolysis of starch into absorbable monosaccharides [4].